Toyoshi Yanagihara
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 37
- Inhalation and Respiratory Drug Delivery 6
- Neonatal Respiratory Health Research 6
-
- Immune Cell Function and Interaction 6
-
- Peptidase Inhibition and Analysis 9
- Cancer Immunotherapy and Biomarkers 9
-
- Sarcoidosis and Beryllium Toxicity Research 10
-
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Co-authors
- Martin KolbSeidai SatoKjetil AskChandak UpaguptaKunihiro SuzukiYoichi NakanishiNaoki HamadaChiko Shimbori
- Journals
- Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)
In The Last Decade
Toyoshi Yanagihara
64 papers receiving 825 citations
Peers
Comparison fields: 5 of 95
- Pulmonary and Respiratory Medicine 423
- Immunology 160
- Oncology 135
- Immunology and Allergy 28
- Physiology 107
Countries citing papers authored by Toyoshi Yanagihara
This map shows the geographic impact of Toyoshi Yanagihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toyoshi Yanagihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toyoshi Yanagihara more than expected).
Fields of papers citing papers by Toyoshi Yanagihara
This network shows the impact of papers produced by Toyoshi Yanagihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toyoshi Yanagihara. The network helps show where Toyoshi Yanagihara may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toyoshi Yanagihara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 24 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 0 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2023 | 0 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 18 | |
| 18 | 2021 | 5 | |
| 19 | 2020 | 14 | |
| 20 | 2018 | 17 |
About Toyoshi Yanagihara
Toyoshi Yanagihara is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 79 papers that have together received 833 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (37 papers), Sarcoidosis and Beryllium Toxicity Research (10 papers), Peptidase Inhibition and Analysis (9 papers), Cancer Immunotherapy and Biomarkers (9 papers), Inhalation and Respiratory Drug Delivery (6 papers), Neonatal Respiratory Health Research (6 papers), Immune Cell Function and Interaction (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (423 citations), Immunology (160 citations) and Oncology (135 citations). Toyoshi Yanagihara has collaborated with scholars based in Japan, Canada and Australia. Frequent co-authors include Martin Kolb, Seidai Sato, Kjetil Ask, Chandak Upagupta, Kunihiro Suzuki, Yoichi Nakanishi, Naoki Hamada, Chiko Shimbori, Pierre‐Simon Bellaye and Yoshinori Fukui. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.